Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDiscoverIE Regulatory News (DSCV)

Share Price Information for DiscoverIE (DSCV)

Share Price is delayed by 15 minutes
Get Live Data
685.00    0.00 (0.00%)
Bid:
682.00
Ask:
686.00
Spread: 4.00 (0.587%)
Market Cap: £665.28m
DSCV Live PriceLast checked at - London Stock Exchange

Intraday DiscoverIE Share Chart

Total Voting Rights

28 Mar 2013 12:29

RNS Number : 1482B
Acal PLC
28 March 2013
 



 

Changes in directors' interests and total voting rights

Acal plc (LSE: ACL, "Acal" or the "Company"), a leading European specialist electronics supplier, announces that the Placing announced on 8 March 2013 has completed following Admission at 8:00am today.

For the purposes of the Financial Services Authority's Disclosure and Transparency Rule 5.6.1, following the admission of 2,816,074 new ordinary shares to the premium listing segment of the Official List today, the Company's total issued ordinary share capital comprises of 31,295,878 ordinary shares of 5 pence each with one voting right per share. The Company does not hold any shares in treasury. Therefore the total number of voting rights as at 28 March 2013 in the Company is 31,295,878. The above figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the Financial Services Authority's Disclosure and Transparency Rules.

Further to the expected subscriptions, announced on 8 March 2013, by certain Directors through the Placing at the Placing Price, the Company has today been notified that the following Directors have subscribed for the corresponding number of Ordinary shares at a price of £2.15 per share. Following this transaction each of these individuals holds the number of Ordinary Shares listed below, representing the corresponding percentage of the existing ordinary share capital of the Company.

 

 

Shares subscribed

Total Ordinary shares post subscription

New % shareholding

Simon Gibbins

9,302

14,365

0.05%

Eric Barton

9,000

30,000

0.10%

Graham Williams

200

1,200

 

 

 

For further information please contact:

Acal plc

Nick Jefferies - Group Chief Executive

Simon Gibbins - Group Finance Director

01483 544500

Cubitt Consulting

Gareth David

Cebuan Bliss

020 7367 5100

 

Notes to Editors:

About Acal plc

Acal is a European leader in advanced technology solutions, providing marketing, engineering, design, manufacturing and other services through two divisions: Specialist Electronics and Supply Chain.

The Electronics division is a leading European specialist electronics supplier and the only such provider with an infrastructure to deliver a broad complementary range of specialist products and bespoke solutions across Europe. The Electronics division has completed four acquisitions in the last three years, more than doubling its underlying Electronics revenues. Acal's long term strategy is to gain significant additional market share through both organic growth and acquisition and to further enhance its value adding capabilities. The Supply Chain division provides inventory optimisation and outsource solutions to leading technology service providers.

Acal has operating companies in the UK, Netherlands, Belgium, Germany, France, Italy, South Africa, Spain, the Nordic region and South Korea.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCMMGZFZRLGFZM
Date   Source Headline
11th Jun 202610:00 amRNSDirector LTIP & DSBP Awards
3rd Jun 20267:00 amRNSPreliminary results
20th May 20267:00 amRNSNotice of Full Year Results
19th May 20267:00 amRNSAcquisition of 3Gmetalworx
7th May 20261:29 pmRNSNotification of Major Holdings
17th Apr 20267:00 amRNSQ4 and full year trading update
10th Apr 20269:16 amRNSNotification of Major Holdings
27th Feb 20264:42 pmRNSNotification of Major Holdings
12th Feb 20265:18 pmRNSDirector/PDMR Shareholding
2nd Feb 20267:00 amRNSQ3 Trading Update
29th Jan 20268:58 amRNSDirector/PDMR Shareholding
16th Dec 20254:00 pmRNSNotification of Major Holdings
16th Dec 20259:31 amRNSIssue of Equity & Total Voting Rights
11th Dec 20254:02 pmRNSDirector/PDMR Shareholding
4th Dec 20257:00 amRNSAcquisition of Trival
3rd Dec 20252:55 pmRNSNotification of Major Holdings
2nd Dec 20257:00 amRNSInterim Results
19th Nov 20257:15 amRNSDirector Declaration
18th Nov 20259:16 amRNSNotice of Half Year Results
28th Oct 20257:00 amRNSAppointment of Joint Corporate Broker
16th Oct 20253:41 pmRNSNotification of Major Holdings
14th Oct 20257:00 amRNSFirst Half Trading Update
15th Sep 20252:14 pmRNSNotification of Major Holdings
4th Sep 20252:58 pmRNSNotification of Major Holdings
14th Aug 20251:27 pmRNSDirector/PDMR Shareholding
13th Aug 20258:32 amRNSDirector / PDMR Shareholding
4th Aug 20253:44 pmRNSNotification of Major Holdings
24th Jul 20252:37 pmRNSResults of Annual General Meeting
24th Jul 20257:00 amRNSTrading Update
19th Jun 202511:34 amRNSAnnual Report & Notice of AGM
18th Jun 20258:12 amRNSNotification of Major Holdings
16th Jun 20254:30 pmRNSNotification of Major Holdings
12th Jun 202510:20 amRNSDirector LTIP & DSBP Awards
4th Jun 20257:00 amRNSPreliminary results
14th May 20254:13 pmRNSNotification of Major Holdings
14th May 20252:13 pmRNSNotice of Full Year Results
16th Apr 20254:48 pmRNSNotification of Major Holdings
16th Apr 20257:00 amRNSTrading Update
9th Apr 20258:38 amRNSNotification of Major Holdings
26th Mar 20253:08 pmRNSNotification of Major Holdings
12th Mar 20258:39 amRNSDirector/PDMR Shareholdings
5th Mar 20258:05 amRNSDirector Declaration
3rd Mar 20252:20 pmRNSDirector/PDMR Shareholding
26th Feb 20254:56 pmRNSNotification of Major Holdings
18th Feb 20252:52 pmRNSNotification of Major Holdings
17th Feb 20252:37 pmRNSNotification of Major Holdings
14th Feb 20258:28 amRNSDirector / PDMR Shareholding
5th Feb 20251:08 pmRNSNotification of Major Holdings
30th Jan 20257:00 amRNSQ3 Trading Update
29th Jan 20259:40 amRNSDirector / PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.